CR11873A - Nuevas carboxamidas heterociclicas para su uso como inhibidores de trombina - Google Patents

Nuevas carboxamidas heterociclicas para su uso como inhibidores de trombina

Info

Publication number
CR11873A
CR11873A CR11873A CR11873A CR11873A CR 11873 A CR11873 A CR 11873A CR 11873 A CR11873 A CR 11873A CR 11873 A CR11873 A CR 11873A CR 11873 A CR11873 A CR 11873A
Authority
CR
Costa Rica
Prior art keywords
carboxamids
thrombin inhibitors
heterociclic
new
new heterociclic
Prior art date
Application number
CR11873A
Other languages
English (en)
Inventor
Branalt Jonas
Gustafsson David
Nilsson Ingemar
Polla Magnus
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of CR11873A publication Critical patent/CR11873A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Esta invención se ralaciona con nuevos compuestos farmacéuticamente útiles de la fórmula (I), en particular compuestos que son inhibidores competitivos de las serina proteasas similares a la tripsina, especialmente la trombina, su uso como medicamentos, las composiciones farmacéuticas que los contienen y las rutas sintéticas para su producción.
CR11873A 2008-06-23 2010-12-23 Nuevas carboxamidas heterociclicas para su uso como inhibidores de trombina CR11873A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7473608P 2008-06-23 2008-06-23
US10238108P 2008-10-03 2008-10-03

Publications (1)

Publication Number Publication Date
CR11873A true CR11873A (es) 2011-02-28

Family

ID=41431868

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11873A CR11873A (es) 2008-06-23 2010-12-23 Nuevas carboxamidas heterociclicas para su uso como inhibidores de trombina

Country Status (20)

Country Link
US (2) US20110130432A1 (es)
EP (1) EP2321301A4 (es)
JP (1) JP2011525487A (es)
KR (1) KR20110025970A (es)
CN (1) CN102131802A (es)
AR (1) AR072278A1 (es)
AU (1) AU2009263076B2 (es)
BR (1) BRPI0914323A2 (es)
CA (1) CA2727925A1 (es)
CO (1) CO6321275A2 (es)
CR (1) CR11873A (es)
DO (1) DOP2010000402A (es)
EA (1) EA018502B1 (es)
EC (1) ECSP10010710A (es)
IL (1) IL210076A0 (es)
MX (1) MX2010014229A (es)
TW (1) TW201002689A (es)
UY (1) UY31923A (es)
WO (1) WO2009157860A1 (es)
ZA (1) ZA201100568B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8354444B2 (en) 2008-09-18 2013-01-15 Hoffmann-La Roche Inc. Substituted pyrrolidine-2-carboxamides
RU2570896C2 (ru) * 2013-04-23 2015-12-20 Общество с ограниченной ответственностью "Химико-фармацевтические технологии" (ООО "ХимФармТех") (4-фтор-бензил)-этил-(2-тетразол-1-ил-фенил)-амин и способ его получения
CN104610184A (zh) * 2015-01-13 2015-05-13 佛山市赛维斯医药科技有限公司 苯二烯四氮唑类化合物、其制备方法和用途
CN104529923B (zh) * 2015-01-13 2016-06-01 佛山市赛维斯医药科技有限公司 二烯四氮唑硝基苯类化合物、其制备方法和用途
MX2020002010A (es) 2017-08-21 2020-07-13 Celgene Corp Procesos para la preparacion de 4,5-diamino-5-oxopentanoato de (s)-terc-butilo.
CN113636982A (zh) * 2021-04-28 2021-11-12 合肥工业大学 一种肉桂酸衍生物及其制备方法和用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW394760B (en) 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
EP0820453A4 (en) * 1995-04-04 2001-08-29 Merck & Co Inc THROMBIN INHIBITORS
AR013084A1 (es) * 1997-06-19 2000-12-13 Astrazeneca Ab Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados
US6353023B1 (en) 1997-08-28 2002-03-05 Pharmacia & Upjohn Company Inhibitors of protein tyrosine phosphatase
KR100689923B1 (ko) * 1998-01-26 2007-03-09 애보트 게엠베하 운트 콤파니 카게 트롬빈 억제제
US6482921B1 (en) 1999-01-28 2002-11-19 Essential Therapeutics, Inc. Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use
FR2793248B1 (fr) * 1999-05-03 2001-06-29 Adir Nouveaux derives de 2,3-methano-aminoacides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
SE0001803D0 (sv) * 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
AU2002230836A1 (en) * 2000-12-18 2002-07-01 Merck & Co., Inc. Benzylamine derivatives and their use as thrombin inhibitors
US6528503B2 (en) * 2000-12-18 2003-03-04 Merck & Co., Inc. Thrombin inhibitors
CA2436176A1 (en) * 2001-02-09 2002-08-22 Merck & Co., Inc. Thrombin inhibitors
UA78195C2 (uk) * 2001-08-30 2007-03-15 Astrazeneca Ab Похідні мигдалевої кислоти та їх застосування як інгібіторів тромбіну, фармацевтична композиція на їх основі
AU2003299901A1 (en) * 2002-10-04 2004-05-04 Merck And Co., Inc. Thrombin inhibitors
GB0327761D0 (en) 2003-11-29 2003-12-31 Astrazeneca Ab Compounds
CN101553219B (zh) 2006-12-06 2013-04-24 塞诺菲-安万特股份有限公司 作为TAFIa抑制剂的脲和磺酰胺衍生物
TW200911787A (en) 2007-07-03 2009-03-16 Astrazeneca Ab New aza-bicyclohexane compounds useful as inhibitors of thrombin
ES2494390T3 (es) 2008-06-06 2014-09-15 Sanofi Derivados macrocíclicos de urea y de sulfamida como inhibidores de TAFIa

Also Published As

Publication number Publication date
DOP2010000402A (es) 2011-01-15
UY31923A (es) 2010-01-29
MX2010014229A (es) 2011-06-20
ZA201100568B (en) 2012-06-27
WO2009157860A1 (en) 2009-12-30
EA201001823A1 (ru) 2011-06-30
CA2727925A1 (en) 2009-12-30
EA018502B1 (ru) 2013-08-30
KR20110025970A (ko) 2011-03-14
EP2321301A1 (en) 2011-05-18
AR072278A1 (es) 2010-08-18
US20110130432A1 (en) 2011-06-02
IL210076A0 (en) 2011-02-28
BRPI0914323A2 (pt) 2017-03-28
US8119673B2 (en) 2012-02-21
EP2321301A4 (en) 2011-09-28
ECSP10010710A (es) 2011-01-31
AU2009263076A1 (en) 2009-12-30
TW201002689A (en) 2010-01-16
CO6321275A2 (es) 2011-09-20
US20090318517A1 (en) 2009-12-24
JP2011525487A (ja) 2011-09-22
AU2009263076B2 (en) 2012-07-26
CN102131802A (zh) 2011-07-20

Similar Documents

Publication Publication Date Title
UY31203A1 (es) Nuevos compuestos de aza-biciclohexano útiles como inhibidores de trombina
CR11618A (es) Inhibidores macrocíclicos de serina proteasa
CO6362015A2 (es) Derivados de acido 1-amino-2ciclobutiletilboronico
CU23840B1 (es) Nuevos derivados de sulfonamida como antagonistas de la bradiquinina
UY30748A1 (es) Compuesto0s novedosos
DOP2010000191A (es) Derivados bis-(sulfonilamino)
SV2010003751A (es) Derivados de isoxazol y su uso como potenciadores de los receptores metabotropicos de glutamato
CR11373A (es) COMPUESTOS DE TIENOPIRIMIDINA Y PIRAZOLOPIRIMIDINA Y SU USO COMO INHIBIDORES DE mTOR CINASA Y PI3 CINASA
ECSP11011184A (es) Compuestos orgánicos
CR20110309A (es) Compuestos orgánicos
ECSP109856A (es) Derivados de oxadiazol y su uso como potenciadores de los receptores metabotrópicos de glutamato - 842
ECSP10010434A (es) Inhibidores de hsp90
CR11518A (es) Compuestos de carbamoilo como inhibidores de dgat1 190
ECSP10010246A (es) Inhibidores de beta-lactamasa
ECSP077271A (es) Derivados de pirimidina
UY31260A1 (es) Compuestos de pirazol, composiciones conteniendolos y aplicaciones.
SV2011003855A (es) Heteroarilos sustituidos
ECSP077259A (es) Derivados de pirimidina
BR112012019042A2 (pt) "inibidores de serina protease tipo tripsina, e sua preparação e uso".
CR11873A (es) Nuevas carboxamidas heterociclicas para su uso como inhibidores de trombina
CU23944B1 (es) Amidas del ácido pirrolidin-1,2-dicarboxílico sustituidas como moduladores de calicreína 7
CL2011002911A1 (es) Compuestos derivados de benzamidas, inhibidores de serina proteasa; composición farmacéutica; uso del compuesto para tratar cáncer.
UY29325A1 (es) Nuevos derivados de 2 - amino-piridina
ECSP14006696A (es) Agentes de reversión anticoagulante
UY32635A (es) Derivados de bis-(sulfonilamino) en terapia 735

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)